SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-186693
Filing Date
2021-06-09
Accepted
2021-06-09 16:01:33
Documents
12
Period of Report
2021-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d114489d8k.htm   iXBRL 8-K 31911
  Complete submission text file 0001193125-21-186693.txt   154504

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arvn-20210608.xsd EX-101.SCH 3065
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20210608_lab.xml EX-101.LAB 18137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20210608_pre.xml EX-101.PRE 11404
5 EXTRACTED XBRL INSTANCE DOCUMENT d114489d8k_htm.xml XML 3354
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 211005132
SIC: 2834 Pharmaceutical Preparations